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Abstract Attention deficit hyperactivity disorder (ADHD)
is now recognized as a common disorder both in child and
adult psychiatry. Adult patients with a diagnosis of ADHD
(n = 572) and community controls (n = 675) responded to
auto-questionnaires rating past and present symptoms of
ADHD, co-morbid conditions, including migraine, treat-
ment history and work status. The prevalence of migraine
was significantly higher in the patient group compared to the
controls (28.3% vs. 19.2%, P \ 0.001, OR = 1.67, CI
1.28–2.17). The difference from controls was particularly
marked for men (22.5% vs. 10.7%, P \ 0.001, OR = 2.43,
CI 1.51–3.90) but was also significant for women (34.4% vs.
24.9%, P = 0.008, OR = 1.58, CI 1.13–2.21). In both
patients and controls, migraine was associated with symp-
toms of mood and anxiety disorders. These findings point to
a co-morbidity of migraine with ADHD, and it is possible
that these patients represent a clinical and biological sub-
group of adult patients with ADHD.
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Introduction
During recent years, attention deficit hyperactivity disorder
(ADHD) has received increasing interest in adult psychiatry
[1–5]. It has become evident that many children with
ADHD still have impairing symptoms as adults which cause
them to suffer both socially and at work [6, 7]. ADHD
prevalence estimates are in the range of 2–12% in children
[8–10] and 1–4% in adults [4, 11, 12]. In addition, ADHD is
associated with many other psychiatric disorders, in par-
ticular anxiety and mood disorders [7, 12], but apart from
asthma [13] and obesity [14], there has been little interest in
the possible co-morbidity with somatic disorders.
Compared to ADHD, migraine has a very different
profile with regard to prevalence, gender distribution and
age of onset [15]. However, both migraine [16, 17] and
ADHD [18] have a strong genetic basis. Furthermore, it is
interesting to observe that migraine has also a well-estab-
lished co-morbid connection with mood and anxiety dis-
orders. This has been shown both in clinical [19–21],
epidemiological [22, 23] and genetic studies [24, 25].
The aims of the present study were to (1) investigate the
prevalence of migraine among clinically diagnosed adults
with ADHD, compared to controls from a normal popula-
tion and (2) investigate whether the presence of migraine is
associated with differences in symptom patterns and
demographic variables in patients and controls.
Methods
Subjects
This is a cross-sectional study of 572 Norwegian patients
diagnosed with adult ADHD and a comparison group of
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675 persons from the general population. The patients were
recruited as part of a genetic study using a national registry
of adults diagnosed with ADHD in Norway during
1997–2005 [7, 26, 27]. The diagnostic assessment of the
patients in the registry was made by one of three national
expert committees for ADHD and was based on detailed
clinical information (including information from infor-
mants) provided by the referring clinicians, mainly psy-
chiatrists. The diagnosis of ADHD was made according to
the ICD-10 research criteria, with two modifications;
allowing the inattentive subtype, as in DSM-IV, as suffi-
cient for the diagnosis, and allowing for the presence of
co-morbid psychiatric disorders, as long as the criteria for
ADHD were present before the appearance of the co-
morbid disorder. In addition, to enhance recruitment and
to include patients diagnosed also later than May 2005,
psychiatrists and psychologists nationwide were invited to
recruit formally diagnosed adult patients with ADHD. The
inclusion criteria were a diagnosis of ADHD according to
the criteria described above and age above 18 years.
There were no formal exclusion criteria. The intention
behind this strategy was to recruit a clinically represen-
tative sample of adult ADHD patients from all over the
country.
A control group was recruited using the database of the
Medical Birth Registry of Norway (MBRN). The MBRN
includes all people born in Norway after 1 January 1967.
Invitation letters were sent out to a randomly selected
sample of persons between 18 and 40 years from all over
Norway. Data from the first 675 persons recruited are
presented in the present report. For further details about the
recruitment strategy and the patient sample, see Johansson
et al. 2008 [27], Halleland et al. 2009 [28], Halmøy et al.
2009 [7], 2010 [26].
Informed consent based on detailed written information
about the project was obtained from all patients and con-
trols. The study was approved by the Regional Research
Ethical Committee of Western Norway.
Questionnaires
The following self-report questionnaires were used in this
study: The Wender Utah Rating Scale (WURS), measuring
the presence and frequency of childhood ADHD symptoms
[29], the Adult ADHD Self-Report Scale (ASRS) that
measures the presence and frequency of current symptoms
of ADHD [30, 31], and the Mood Disorder Questionnaire
(MDQ), a screening questionnaire for bipolar spectrum
disorders (BSD) [32].
The WURS is designed to retrospectively record
symptoms and signs of ADHD in childhood. The version of
the scale used in this study contains 25 questions, each
rated on a 5-point severity scale. The WURS-25 has been
validated by several investigators in different countries and
populations [33, 34].
The ASRS is the World Health Organization’s (WHO)
rating scale for adult ADHD designed to measure current
ADHD symptoms. It consists of 18 items based on DSM-
IV symptoms/criteria for ADHD which are measured on a
5-point scale (0 Never/seldom and 4 Very often), yielding a
possible score range from 0 to 72. The items 1–9 cover the
symptoms of inattention; items 10–18 the symptoms of
hyperactivity and impulsivity. In this study, we used a
continuous scoring method [31].
The MDQ is a screening instrument for BSD that has
been validated for use in the general population and in
psychiatric patient populations [32, 35]. The MDQ consists
of 15 items. The first 13 questions concern periods of life-
time symptoms of mania and hypomania, and the last two
ask about co-occurrence of symptoms and ranking of
functional impairment caused by the symptoms. A standard
MDQ positive score is defined as 7 or more ‘yes’ on the
first 13 items, ‘yes’ on question 14 (co-occurrence of
symptoms) and level ‘3 or more’ on question 15 (moderate
to severe impairment).
In addition, the patients answered questions concerning
socio-demographic and clinical factors including educa-
tional and occupational levels and co-morbid symptoms
and problems. The questions related to co-morbidity were
scored as ‘yes’ or ‘no’. ‘Have you ever experienced sig-
nificant anxiety and/or depression? Have you ever had
problems with alcohol? Have you ever had migraine? Do
you have bipolar or manic-depressive disorder?’.
Statistical analyses
The data were analysed using chi-square tests, t tests for
independent samples and logistic regression analyses. All
analyses were performed using the Statistical Package for
Social Sciences (SPSS) version 15.0.1.
Results
Clinical and socio-demographic characteristics of patients
and controls are shown in Table 1. In the control group,
there were a higher proportion of women than in the patient
group (59.7% vs. 48.4%). The frequency of self-reported
migraine was higher for women both in the control group
(24.9% vs. 10.7%) and among the patients (34.4% vs.
22.5%). Considering these clear gender differences, we
analysed data for men and women separately. For both
genders, the mean age was lower in the control group
compared to the patients. The level of education was lower
among the patients and the relative number holding an
ordinary job far lower. The proportions of patients
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reporting a life-time history of depression and/or anxiety,
bipolar disorder and alcohol problems were significantly
increased compared to the controls, and scores on all the
self-report scales were far higher in the patient group than
in the control group. All these differences were similar for
men and women.
In the patient group, 28.3% reported having migraine,
compared to 19.2% among controls (P \ 0.001, chi-
square, OR = 1.67, 1.28–2.17). When controlling for
gender and age in a logistic regression, the OR was only
slightly altered (OR = 1.65, 1.24–2.20). The difference in
migraine prevalence between patients and controls was
somewhat higher for men (OR = 2.43, 1.51–3.90,
P \ 0.001, chi-square) than for women (OR = 1.58,
1.13–2.21, P = 0.008, chi-square).
Table 2 shows the same clinical and socio-demographic
characteristics as in Table 1, but this time contrasting
ADHD patients with and without self-reported migraine.
For both genders, the educational and occupational levels
were very similar for patients with and without migraine.
Self-reported problems with alcohol did not differ, but
more patients with migraine reported a life-time history of
depression and/or anxiety, and the findings were very
similar for men and women. However, bipolar disorder was
reported significantly more often by men with migraine
(21.3%, compared to controls 7.5%), but not by women
(12.5% vs. 12.4%). The reported levels of ADHD symp-
toms in childhood (WURS), current ADHD symptoms
(ASRS score) and life-time symptoms of bipolar disorder
(MDQ) did not differ between the two groups.
In Table 3 are shown the characteristics of controls with
and without migraine. The proportion of women was
higher in the group with migraine (77.5% vs. 55.5%).
Women with migraine had a slightly lower level of edu-
cation than women without migraine, and the number
holding a job was lower for men with migraine compared
to men without migraine. For both genders, the proportions
of self-reported depression and/or anxiety were markedly
higher in the migraine groups. However, only men with
migraine reported a higher frequency of bipolar disorder
(10.3% vs. 0.4%) and problems with alcohol (10.3% vs.
1.7%) compared to men without migraine, with no differ-
ences among women. On a symptom level, persons with
migraine, both men and women, reported more ADHD
symptoms in childhood (WURS), and women had also
significantly higher scores on current ADHD symptoms
(ASRS). The proportion screening positive for bipolar
disorder (MDQ) was also higher in the migraine groups, for
both genders.
Discussion
The main finding of the present study is a higher preva-
lence of migraine in a clinical sample of adult patients with
persistent ADHD, compared to a control group from the
general population. Among the controls, the presence of
migraine was associated with higher scores on two self-
report forms providing information on ADHD symptoms
(WURS, both genders, and ASRS, women only), giving
Table 1 Clinical and socio-demographic characteristics of patients and controls
Males Females
Patients N = 290 Controls N = 271 P Patients N = 274 Controls N = 402 P
Age (mean ± SD) 33.9 30.3 \0.001 34.4 29.0 \0.001
Educational level (%)
Junior high school 30.6 4.2 23.5 4.7
Senior high school 46.9 39.4 51.4 35.7
College/university 22.4 56.4 \0.001 25.1 59.7 \0.001
Occupational level (%)
Working 30.7 83.0 \0.001 27.4 79.9 \0.001
Self-reported co-morbidity (%)
Depression/anxiety 66.2 14.9 \0.001 71.8 16.5 \0.001
Bipolar disorder 10.7 1.5 \0.001 12.3 1.2 \0.001
Alcohol problems 32.6 2.9 \0.001 15.1 1.7 \0.001
WURS (score, range 0–100) 58.2 19.1 \0.001 59.6 16.3 \0.001
ASRS (score 0–72) 44.2 23.5 \0.001 47.7 22.2 \0.001
MDQ? (%) 54.7 9.0 \0.001 42.2 4.9 \0.001
Migraine (%) 22.5 10.7 \0.001 34.4 24.9 0.008
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additional support for the contention that migraine is
related to ADHD.
The ADHD patients in the present study are very
impaired as a group, with a low level of education com-
pared to controls, and less than one-third being employed
[7]. This is in line with previous studies showing a low
level of occupational functioning in adult patients with
persistent ADHD [6]. Clinical and socio-demographic
characteristics of these patients have been described in
previous publications [7, 27, 28], including the relationship
between ADHD and bipolar spectrum disorders [26].
It has been suggested that bipolar disorder associated
with migraine might represent a more severe variant of
bipolar disorder, based on an earlier onset of the bipolar
disorder and greater social impairment [36, 37]. However,
other studies do not support such a contention [38]. We
Table 2 Clinical and socio-demographic characteristics of patients with and without migraine
Males Females
Migraine N = 64 Not migraine N = 221 P Migraine N = 93 Not migraine N = 177 P
Age (mean ± SD) 34.7 33.8 NS 35.6 34.0 NS
Educational level (%)
Junior high school 32.1 30.9 24.1 23.4
Senior high school 41.5 48.2 50.6 51.3
College/university 26.4 20.9 NS 25.3 25.3 NS
Occupational level (%)
Working 36.1 29.3 NS 21.6 30.1 NS
Self-reported co-morbidity (%)
Depression/anxiety 78.1 63.0 0.024 79.8 67.2 0.029
Bipolar disorder 21.3 7.5 0.002 12.5 12.4 NS
Alcohol problems 35.9 31.8 NS 19.6 13.0 NS
WURS (score, range 0–100) 58.9 58.1 NS 62.2 58.2 NS
ASRS (score 0–72) 46.9 43.5 NS 48.8 47.0 NS
MDQ? (%) 49.2 56.6 NS 40.7 42.9 NS
NS Not significant
Table 3 Clinical and socio-demographic characteristics of controls with and without migraine
Males Females
Migraine N = 29 Not migraine N = 241 P Migraine N = 100 Not migraine N = 302 P
Age (mean ± SD) 30.8 30.3 NS 30.7 28.5 0.004
Educational level (%)
Junior high school 3.4 3.9 8.3 3.4
Senior high school 34.5 40.2 41.7 33.9
College/university 62.1 55.9 NS 50.0 62.7 0.031
Occupational level (%)
Working 72.0 84.7 0.002 81.5 79.3 NS
Self-reported co-morbidity (%)
Depression/anxiety 31.0 12.1 0.006 25.0 14.0 0.01
Bipolar disorder 10.3 0.4 0.002 2.0 1.0 NS
Alcohol problems 10.3 1.7 0.005 3.0 1.3 NS
WURS (score, range 0–100) 25.5 18.1 0.009 19.2 15.3 0.014
ASRS (score 0–72) 24.7 23.2 NS 24.3 21.7 0.025
MDQ? (%) 18.5 7.1 0.041 9.3 3.8 0.035
NS Not significant
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found no indication that ADHD patients with migraine
represent a more impaired subgroup of ADHD patients.
The level of education, employment status and scores on
the ASRS and WURS scales were not significantly dif-
ferent from patients without migraine. However, among the
controls, the presence of migraine in women was associ-
ated with a lower level of education, and in men with a
lower likelihood of being employed.
In epidemiological studies, migraine is clearly more
prevalent in women than in men [15, 39–41]. This was also
found for the controls in the present study, 25% of the
women reported migraine, compared to 11% of the men.
These prevalence figures are somewhat higher compared to
a previous epidemiological study from Norway, reporting a
prevalence of 16% in women and 8% in men [42]. In
several clinical investigations of patients with mood dis-
orders and migraine co-morbidity, gender differences are
far less marked. In a study from Bergen, we found that 42%
of men compared to 55% of women with mood disorders
had migraine [38]. Low and co-workers [21] described
comparable findings in bipolar patients; 31% of men and
44% of women met the criteria for migraine. Similarly,
Mahmood, Romans and Silverstone [36] found, in a sample
of bipolar patients, an almost equal prevalence of migraine
in men (25%) and women (27%). Kececi et al. [43]
reported, in a population study from Turkey, that major
depression was strongly associated with migraine, and
although the prevalence of major depression was higher in
women (22% vs. 9%), in persons with migraine this gender
difference in prevalence was no longer present (33%
prevalence of major depression in women vs. 32% in men).
In the present study, the prevalence of migraine in female
ADHD patients (34%) was higher than in men (23%), but
the difference was smaller than one would expect from a
random population sample. Therefore, it seems that the
relationship between migraine, ADHD, and gender in our
patient sample resembles findings from patients with mood
disorders.
The present results imply a co-morbidity between
ADHD and migraine. This may appear counterintuitive.
Migraine and ADHD are very different disorders. Migraine
is an episodic disorder, with attacks of pain and time-
limited neurological dysfunction [15]. Several genetic
variants have been identified to cause migraine in subsets
of patients, providing a valid model for disturbances
causing hyperexcitability of neurons and migraine symp-
toms [44]. In contrast, ADHD is a chronic disorder com-
prising problems with attention and concentration,
combined with behavioural symptoms such as hyper-
activity/restlessness and impulsivity [2]. Deficits of exec-
utive function are probably of central importance [2, 5].
However, our contention is that this apparently paradoxical
relationship between migraine and ADHD may be related
to their shared co-morbidities and possibly related patho-
genetic mechanisms. Co-morbid psychiatric disorders were
highly prevalent in our sample of ADHD patients. We
found a higher frequency of depression and/or anxiety in
ADHD patients with migraine compared to ADHD patients
without migraine, both in men and in women. Self-reported
bipolar disorder was higher in male ADHD patients with
migraine, but not in women. However, migraine was not
associated with a higher number of patients having positive
scores on the MDQ scale.
There is a well-documented co-morbidity between
migraine and psychiatric disorders, in particular mood and
anxiety disorders [38, 45, 46]. This was also seen in the
controls from the present study, those having migraine
reported more depression and/or anxiety, and men also
reported more bipolar disorder. Furthermore, a larger
number had positive scores on the MDQ scale, both men
and women. The same pattern of co-morbidity with mood
and anxiety disorders is seen for ADHD [12]. Concerning
bipolar disorders, both migraine [19] and ADHD [47] may
be linked to bipolar II disorder. Increased motor activity
and impulsivity are central symptoms of both ADHD [2]
and bipolar disorders [48]. Impulsivity is not regarded as a
part of the ordinary symptom pattern of migraine, but the
connection of migraine with bipolar disorders, and the
finding of a high frequency of migraine (44%) among
patients (predominantly men) with intermittent explosive
disorder [49], suggest that impulsivity and/or mood dys-
regulation may be a common link between migraine and
ADHD.
Cognitive dysfunction is not thought to be associated
with migraine, apart from changes occurring during acute
attacks [15, 50]. However, there is increasing evidence that
there are cognitive impairments in migraine patients in
periods between attacks [51, 52], including slower response
times during cognitive set-shifting and deficits in memory.
All these findings point to a possible link of migraine with
ADHD.
While it is not possible on the basis of such a cross-
sectional study to answer the question of why such a
connection between migraine and ADHD exists, it is
tempting to speculate that this is related to common
underlying pathophysiological mechanisms. Much of the
current thinking on the pathophysiology and genetics of
ADHD has focused on alterations in dopaminergic systems
[27], and there is also substantial evidence that dopami-
nergic mechanisms are involved both in migraine [23, 53]
and in mood disorders [54, 55]. It is therefore possible that
changes in dopaminergic systems or other signalling
mechanisms represent common etiological factors for these
disorders and that there could be a subgroup of patients
sharing underlying pathophysiological disturbances caus-
ing hyperexcitability of neurons and symptoms of
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combined neuropsychiatric disorders like migraine, ADHD
and mood disorders.
Recent genome-wide association studies have revealed
unique susceptibility genes for co-morbid migraine and
bipolar disorder. Interestingly, one of these genes was also
associated with co-morbid ADHD and migraine, support-
ing the hypothesis that migraine has shared pathogenetic
mechanisms with ADHD and mood disorders [56].
Concerning limitations, it is evident that we are not
studying the whole range of ADHD patients. Not all
patients with such problems consult a doctor, and those
who are recruited to the present study probably represent a
more severely affected group [7]. It is therefore uncertain if
the present results are applicable to ADHD patients in
general. The ASRS, the WURS and the MDQ are well-
known and widely used auto-questionnaires, and even
though they have not been subject to official validations in
Norway, validation studies performed in various other
populations have found them suitable for use [7, 26]. The
diagnosis of migraine was made on the basis of self-
reports, and this is obviously a departure from the ideal. It
is a limitation of the present study that diagnoses were not
obtained by a doctor skilled in the diagnosis of migraine.
However, a diagnosis of migraine on the basis of ques-
tionnaires is inherently difficult [57], and it is not certain
that a more detailed questionnaire would have given more
valid results [58, 59]. Furthermore, asking for the persons’
own opinion concerning migraine will give prevalence
figures that include persons who have migraine without
ever consulting a doctor because of such a complaint [60,
61]. We have no reason to suppose that the patient and
control groups are different in this regard. We therefore
consider that the present findings on migraine prevalence
are valid, allowing for a comparison of ADHD patients and
controls. With regard to the other questions on co-mor-
bidity, we have, in a separate paper, shown that for ADHD
patients there is a moderate to strong correlation between
self-reported problems and formal diagnoses obtained
during a clinical interview, for depression/anxiety and
alcohol problems, and a moderate to weak correlation
between self-reported and interview-diagnosed bipolar
disorder [26].
In conclusion, we have shown that adults with persistent
ADHD have an increased prevalence of migraine com-
pared to controls from the general population. This points
to a co-morbidity between these two disorders of the brain,
possibly related to their shared underlying pathophysiolo-
gies and co-morbidities with other neuropsychiatric disor-
ders, like mood and anxiety disorders. We suggest that
future studies should explore underlying pathophysiologi-
cal mechanisms that may explain the co-occurrence of
ADHD and migraine.
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